In the restricted analysis including only BC affected and unaffected women, LOF variant carriers had a significant OR of 2.42 (95% CI: 1.12–5.23) in the upper tertile of insulin concentration compared to carriers of nonsynonymous variants. The gene discussed is INS; the disease is breast cancer.